U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07097831) titled 'A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects' on July 24.

Brief Summary: The study was designed to evaluate the pharmacokinetic effects of rosuvastatin calcium tablets after oral administration of HRS-1301 in healthy subjects.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Hyperlipidemia

Intervention: DRUG: HRS-1301 Tablets

HRS-1301 tablets.

DRUG: Rosuvastatin Calcium Tablets

Rosuvastatin calcium tablets.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shandong Suncadia Medicine Co., Ltd.

Disclaimer: Curated by HT Syndication....